Home / Inspections / 961640

FDA Inspection 961640 — Seattle Reproductive Medicine, Inc., P.S.

Seattle Reproductive Medicine, Inc., P.S. — FEI 3009672546

The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on February 10, 2016 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 10, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bellevue, WA (United States)

Facility

Other inspections at this facility

  • 1293422 (NAI Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1171334 (NAI Thu Apr 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031414 (NAI Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865541 (NAI Mon Feb 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources